Evogene
EVGN
14 hedge funds and large institutions have $176K invested in Evogene in 2025 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 3 increasing their positions, 4 reducing their positions, and 3 closing their positions.
5% more capital invested
Capital invested by funds: $167K → $176K (+$9.16K)
1.96% less ownership
Funds ownership: 1.96% → 0% (-2%)
13% less funds holding
Funds holding: 16 → 14 (-2)
25% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 4
67% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$45.8K |
| 2 |
Jane Street
New York
|
+$30.9K |
| 3 |
Morgan Stanley
New York
|
+$19.2K |
| 4 |
AS
Altshuler Shaham
Tel Aviv,
Israel
|
+$950 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VF
Virtu Financial
New York
|
-$41K |
| 2 |
TSS
Two Sigma Securities
New York
|
-$12.3K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$7K |
| 4 |
BNP Paribas Financial Markets
Paris,
France
|
-$3.66K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$2.93K |
EVGN Hedge Fund Activity: Q3 2025 in Review
14 of the 7,631 institutional investors tracked by Wall St. Rank reported a position in Evogene (EVGN) for Q3 2025, worth a combined $176K — up 5.5% from $167K a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of EVGN and 1 opened new positions — a net loss of 2 holders — while 4 trimmed existing stakes and 3 added.
The largest buyer was Citadel Advisors, adding an estimated $45.8K. The largest seller was Virtu Financial, exiting entirely with an estimated $41K sold.
- 14 institutional investors held Evogene (EVGN) as of Q3 2025, down from 16 in Q2 2025.
- Funds reported $176K of Evogene stock for Q3 2025, up 5.5% quarter-over-quarter.
- 1 fund opened new Evogene positions in Q3 2025 and 3 closed out, a net change of -2 holders.
- The largest Evogene buyer in Q3 2025 was Citadel Advisors, an estimated $45.8K added.
- The largest Evogene seller in Q3 2025 was Virtu Financial, an estimated $41K sold.
Based on aggregated 13F filings for Q3 2025.